iCAD, Inc. (ICAD) DCF Valuation

ICAD, Inc. (ICAD) DCF Valoración

US | Healthcare | Medical - Devices | NASDAQ
iCAD, Inc. (ICAD) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

iCAD, Inc. (ICAD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora DCF ICAD, Inc. (ICAD)! Obtenga datos financieros reales para ICAD, modifique las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estos ajustes afectan el valor intrínseco de ICAD, Inc. (ICAD).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 31.3 29.7 33.6 27.9 17.3 15.3 13.5 11.9 10.5 9.3
Revenue Growth, % 0 -5.24 13.27 -16.93 -38.03 -11.73 -11.73 -11.73 -11.73 -11.73
EBITDA -12.1 -16.5 -10.5 -9.5 -6.6 -6.0 -5.3 -4.7 -4.1 -3.7
EBITDA, % -38.45 -55.62 -31.35 -34.01 -37.91 -39.47 -39.47 -39.47 -39.47 -39.47
Depreciation .7 .6 .6 .5 .4 .3 .3 .2 .2 .2
Depreciation, % 2.15 1.95 1.66 1.86 2.36 2 2 2 2 2
EBIT -12.7 -17.1 -11.1 -10.0 -7.0 -6.3 -5.6 -4.9 -4.4 -3.8
EBIT, % -40.6 -57.57 -33.01 -35.87 -40.27 -41.46 -41.46 -41.46 -41.46 -41.46
Total Cash 15.3 27.2 34.3 21.3 21.7 12.7 11.2 9.9 8.8 7.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 9.8 10.5 10.8 6.5 6.4
Account Receivables, % 31.33 35.38 32.06 23.32 36.91
Inventories 2.6 3.1 4.2 5.4 .9 1.7 1.5 1.3 1.2 1.0
Inventories, % 8.33 10.59 12.4 19.28 5.3 11.18 11.18 11.18 11.18 11.18
Accounts Payable 2.0 2.9 2.8 1.4 .7 1.0 .9 .8 .7 .6
Accounts Payable, % 6.35 9.66 8.26 5.17 4.11 6.71 6.71 6.71 6.71 6.71
Capital Expenditure -.3 -.5 -.6 -.5 -1.3 -.4 -.4 -.3 -.3 -.3
Capital Expenditure, % -0.97639 -1.6 -1.75 -1.91 -7.3 -2.71 -2.71 -2.71 -2.71 -2.71
Tax Rate, % 30.66 30.66 30.66 30.66 30.66 30.66 30.66 30.66 30.66 30.66
EBITAT -12.8 -17.1 -11.1 -9.9 -4.8 -5.9 -5.2 -4.6 -4.1 -3.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -22.8 -17.4 -12.5 -8.2 -1.8 -5.0 -4.7 -4.1 -3.7 -3.2
WACC, % 11.35 11.35 11.35 11.35 11.34 11.35 11.35 11.35 11.35 11.35
PV UFCF
SUM PV UFCF -15.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -3
Terminal Value -35
Present Terminal Value -21
Enterprise Value -36
Net Debt -21
Equity Value -15
Diluted Shares Outstanding, MM 26
Equity Value Per Share -0.58

What You Will Get

  • Pre-Filled Financial Model: iCAD’s actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
  • Instant Calculations: Real-time updates provide immediate results as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.

Key Features

  • 🔍 Real-Life ICAD Financials: Pre-filled historical and projected data for iCAD, Inc. (ICAD).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate iCAD’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize iCAD’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Get the pre-formatted Excel file containing iCAD, Inc.'s (ICAD) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and evaluate results instantly.
  • Make Decisions: Leverage the valuation outcomes to shape your investment approach.

Why Choose iCAD, Inc. (ICAD)?

  • Streamlined Process: No need to navigate complex systems – our solutions are user-friendly and efficient.
  • Enhanced Precision: Accurate data and advanced algorithms minimize discrepancies in outcomes.
  • Completely Adaptable: Modify our tools to fit your specific needs and strategic goals.
  • User-Friendly Interface: Intuitive designs and visuals facilitate easy understanding of results.
  • Endorsed by Industry Leaders: Built for professionals who prioritize accuracy and effectiveness.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling iCAD, Inc. (ICAD) stock.
  • Financial Analysts: Enhance valuation processes with ready-to-use financial models for iCAD, Inc. (ICAD).
  • Consultants: Provide accurate valuation insights for clients regarding iCAD, Inc. (ICAD) quickly and efficiently.
  • Business Owners: Gain insights into how companies like iCAD, Inc. (ICAD) are valued to inform your own business strategies.
  • Finance Students: Explore valuation techniques using real-world data and scenarios related to iCAD, Inc. (ICAD).

What the Template Contains

  • Preloaded ICAD Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.